Research ArticleExperimental Studies
Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer
BRANISLAV BYSTRICKY, SILVIA JURISOVA, MARIAN KARABA, GABRIEL MINARIK, JURAJ BENCA, TATIANA SEDLÁCKOVÁ, LUBOMIRA TOTHOVA, BARBORA VLKOVA, ZUZANA CIERNA, PAVOL JANEGA, DENISA MANASOVA, PAULINA GRONESOVA, DANIEL PINDAK, JOZEF MARDIAK, PETER CELEC and MICHAL MEGO
Anticancer Research April 2017, 37 (4) 1787-1791;
BRANISLAV BYSTRICKY
1Second Department of Medical Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
2Department of Oncology, Faculty Hospital Trencin, Trencin, Slovakia
SILVIA JURISOVA
1Second Department of Medical Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
3National Cancer Institute, Bratislava, Slovakia
MARIAN KARABA
3National Cancer Institute, Bratislava, Slovakia
4Department of Surgery, Slovak Medical University, Bratislava, Slovakia
GABRIEL MINARIK
5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
JURAJ BENCA
3National Cancer Institute, Bratislava, Slovakia
6Department of Medicine, St. Elizabeth University, Bratislava, Slovakia
TATIANA SEDLÁCKOVÁ
5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
LUBOMIRA TOTHOVA
5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
BARBORA VLKOVA
5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
ZUZANA CIERNA
7Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
PAVOL JANEGA
7Department of Pathology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
8Institute of Normal and Pathological Physiology, Bratislava, Slovakia
DENISA MANASOVA
9Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia
PAULINA GRONESOVA
10Cancer Research Institute, Slovak Academy of Sciences, Bratislava, Slovakia
DANIEL PINDAK
3National Cancer Institute, Bratislava, Slovakia
4Department of Surgery, Slovak Medical University, Bratislava, Slovakia
JOZEF MARDIAK
1Second Department of Medical Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
3National Cancer Institute, Bratislava, Slovakia
PETER CELEC
5Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia
MICHAL MEGO
1Second Department of Medical Oncology, Faculty of Medicine, Comenius University, Bratislava, Slovakia
3National Cancer Institute, Bratislava, Slovakia
9Translational Research Unit, Faculty of Medicine, Comenius University, Bratislava, Slovakia
In this issue
Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer
BRANISLAV BYSTRICKY, SILVIA JURISOVA, MARIAN KARABA, GABRIEL MINARIK, JURAJ BENCA, TATIANA SEDLÁCKOVÁ, LUBOMIRA TOTHOVA, BARBORA VLKOVA, ZUZANA CIERNA, PAVOL JANEGA, DENISA MANASOVA, PAULINA GRONESOVA, DANIEL PINDAK, JOZEF MARDIAK, PETER CELEC, MICHAL MEGO
Anticancer Research Apr 2017, 37 (4) 1787-1791;
Relationship Between Circulating Tumor Cells and Tissue Plasminogen Activator in Patients with Early Breast Cancer
BRANISLAV BYSTRICKY, SILVIA JURISOVA, MARIAN KARABA, GABRIEL MINARIK, JURAJ BENCA, TATIANA SEDLÁCKOVÁ, LUBOMIRA TOTHOVA, BARBORA VLKOVA, ZUZANA CIERNA, PAVOL JANEGA, DENISA MANASOVA, PAULINA GRONESOVA, DANIEL PINDAK, JOZEF MARDIAK, PETER CELEC, MICHAL MEGO
Anticancer Research Apr 2017, 37 (4) 1787-1791;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.